0001110803-12-000176.txt : 20121213 0001110803-12-000176.hdr.sgml : 20121213 20121213170718 ACCESSION NUMBER: 0001110803-12-000176 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121213 ITEM INFORMATION: Other Events FILED AS OF DATE: 20121213 DATE AS OF CHANGE: 20121213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA INC CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 121262770 BUSINESS ADDRESS: STREET 1: 9885 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 9885 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 a2012-12x148xkhsr.htm CURRENT REPORT, ITEM 8.01 2012-12-14 8-K HSR


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K
 
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 12, 2012
 
Illumina, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-35406
33-0804655
_______________________________________
(State or other jurisdiction
________________________
(Commission
______________________________
(I.R.S. Employer
of incorporation)
File Number)
Identification No.)
  
 
 
5200 Illumina Way,
San Diego, California
 
92122
____________________________________________________
(Address of principal executive offices)
 
_________________
(Zip Code)

(858) 202-4500
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 8.01
Other Events
On December 12, 2012, Illumina, Inc. received a request for additional information (also known as a “second request”) from the U.S. Federal Trade Commission (“FTC”) in connection with the FTC's review under the Hart-Scott-Rodino Act of Illumina's proposed acquisition of Complete Genomics, Inc.  Illumina intends to continue to work collaboratively with the FTC staff in connection with its review of the proposed acquisition.






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
ILLUMINA, INC.
 
 
 
 
Date:                December 13, 2012
 
By:
 
/s/ Christian G. Cabou
 
 
 
 
Christian G. Cabou
 
 
 
 
Senior Vice President, General Counsel and Secretary